A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.
Christine Gebski, insider at Repligen

Christine Gebski Insider Information

Insider of Repligen
Christine Gebski joined Repligen in May 2015 as Senior Vice President, Filtration and Chromatography where she oversees the general management and strategy of the companies’ upstream and downstream filtration and chromatography portfolio. Ms. Gebski also manages the Customer Service and Field Applications functions within the company, ensuring strong customer experience. Prior to joining Repligen, Ms. Gebski was Head of the Chromatography Business Unit within the Bioproduction Division of Thermo Fisher Scientific. At Thermo Fisher she managed the Global Process Chromatography Applications and R&D functions for ten years. Before joining Thermo Fisher Scientific, Ms. Gebski was a Process Development Scientist for 15 years in the biotechnology industry having held positions of increasing responsibility at Genzyme, TKT/Shire and EMD Pharmaceuticals. She has significant experience in downstream process development and engineering, technology transfer and validation across a variety of biological molecule classes and diagnostic reagents. She holds a B.S. in Biology from the University of Vermont and a M.S. in Biotechnology from the University of Massachusetts at Lowell.

What is Christine Gebski's net worth?

The estimated net worth of Christine Gebski is at least $7.86 million as of August 4th, 2022. Ms. Gebski owns 30,735 shares of Repligen stock worth more than $7,859,862 as of August 15th. This net worth evaluation does not reflect any other investments that Ms. Gebski may own. Additionally, Ms. Gebski receives an annual salary of $685,060.00 as Insider at Repligen. Learn More about Christine Gebski's net worth.

How old is Christine Gebski?

Ms. Gebski is currently 53 years old. There are 4 older executives and no younger executives at Repligen. The oldest executive at Repligen is Mr. Ralf Kuriyel, Sr. VP of R&D, who is 63 years old. Learn More on Christine Gebski's age.

What is Christine Gebski's salary?

As the Insider of Repligen Co., Ms. Gebski earns $685,060.00 per year. There are 4 executives that earn more than Ms. Gebski. The highest earning executive at Repligen is Mr. Anthony J. Hunt, Pres, CEO & Director, who commands a salary of $2,100,000.00 per year. Learn More on Christine Gebski's salary.

How do I contact Christine Gebski?

The corporate mailing address for Ms. Gebski and other Repligen executives is 41 SEYON STREET BUILDING 1 SUITE 100, WALTHAM MA, 02453. Repligen can also be reached via phone at (781) 250-0111 and via email at [email protected] Learn More on Christine Gebski's contact information.

Has Christine Gebski been buying or selling shares of Repligen?

During the past quarter, Christine Gebski has sold $815,784.57 of Repligen stock. Most recently, Christine Gebski sold 3,357 shares of the business's stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $243.01, for a transaction totalling $815,784.57. Following the completion of the sale, the insider now directly owns 30,735 shares of the company's stock, valued at $7,468,912.35. Learn More on Christine Gebski's trading history.

Who are Repligen's active insiders?

Repligen's insider roster includes Nicolas Barthelemy (Director), James Bylund (SVP), Karen Dawes (Director), Christine Gebski (Insider), Anthony Hunt (CEO), Ralf Kuriyel (VP), Thomas Ryan, Jr. (Director), and Jon Snodgres (CFO). Learn More on Repligen's active insiders.

Are insiders buying or selling shares of Repligen?

In the last year, insiders at the biotechnology company sold shares 15 times. They sold a total of 122,903 shares worth more than $29,857,691.92. The most recent insider tranaction occured on August, 11th when VP Ralf Kuriyel sold 4,840 shares worth more than $1,230,908.80. Insiders at Repligen own 1.1 % of the company. Learn More about insider trades at Repligen.

Information on this page was last updated on 8/11/2022.

Christine Gebski Insider Trading History at Repligen

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/4/2022Sell3,357$243.01$815,784.5730,735View SEC Filing Icon  
5/14/2021Sell445$172.25$76,651.2536,695View SEC Filing Icon  
3/16/2021Sell1,400$196.88$275,632.0037,140View SEC Filing Icon  
See Full Table

Christine Gebski Buying and Selling Activity at Repligen

This chart shows Christine Gebski's buying and selling at Repligen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Repligen Company Overview

Repligen logo
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Read More

Today's Range

Now: $255.73
Low: $250.26
High: $258.22

50 Day Range

MA: $183.41
Low: $140.68
High: $256.21

2 Week Range

Now: $255.73
Low: $137.21
High: $327.32

Volume

454,528 shs

Average Volume

526,400 shs

Market Capitalization

$14.19 billion

P/E Ratio

92.32

Dividend Yield

N/A

Beta

1.07
Most profitable less than $5 stock in the world?
This virtually unknown stock trades under a secret name, brings in more cash than IBM, Facebook and Tesla, and trades for just under $5.

Find out why in this "leaked" footage from a former Wall Street money manager.
>>>